Our previous research demonstrated that IMQ- and CpG A-activated pDCs could kill breast cancer cells in vitro and inhibit breast tumor growth in vivo, at which IMQ was more effective than CpG A. However, the effect on pDCs of other TLR7 and TLR9 ligands is less well understood. This evidence concerns the gene TLR9 and breast neoplasm.